[{"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1109-2020", "product_description": "Age Stop Ex, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1459-2020", "product_description": "BC Hemp Co., Full Spectrum Hemp Extract, CBD Oil, Spearmint, 500mg CBD, 1 FL. OZ (30 ML) bottles, Distributed by: B.C. Hemp Co., LLC, P.O. Box 156, Eau Claire, MI 49111", "product_quantity": "25 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003315", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85306", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Bulk product was distributed to one re-packager in California.", "recall_number": "D-1100-2020", "product_description": "LOSARTAN POTASSIUM TABLETS, USP 25 mg, Bulk, Rx only, For Further Manufacturing, Packing or Repackaging only, Manufactured by: Arrow Pharma (Malta) Ltd., Birzebbugia Malta NDC 0591-3745-00", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.", "recall_initiation_date": "20200325", "center_classification_date": "20200407", "report_date": "20200415", "code_info": "Lots 1207344A, exp. date 06/2020;   1207343A, 1207342A, exp. date 07/2020"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021540"], "brand_name": ["CADUET"], "generic_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-2260", "0069-2150", "0069-2170", "0069-2190", "0069-2160", "0069-2180", "0069-2250", "0069-2270", "0069-6180", "0069-6323", "0069-6565", "0069-6747", "0069-7810", "0069-7232", "0069-7654", "0069-7476"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["404011", "404013", "597967", "597977", "597980", "597984", "597987", "597990", "750199", "750203", "750207", "750211", "750227", "750231", "750235", "750239"], "spl_id": ["1ce17020-050b-4fdc-8201-1a5648ca8a66"], "spl_set_id": ["6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6"], "package_ndc": ["0069-2150-30", "0069-2170-30", "0069-2190-30", "0069-2260-30", "0069-2160-30", "0069-2180-30", "0069-2250-30", "0069-2270-30", "0069-6180-30", "0069-6323-30", "0069-6565-30", "0069-6747-30", "0069-7810-30", "0069-7232-30", "0069-7654-30", "0069-7476-30"], "is_original_packager": [true], "upc": ["0300692150305", "0300692250302", "0300692170303", "0300692160304", "0300692190301", "0300696565303", "0300696747303", "0300697810303", "0300692270300", "0300697232303", "0300697476301", "0300696180308", "0300696323309", "0300692260301", "0300697654303"], "unii": ["864V2Q084H", "48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "84860", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0841-2020", "product_description": "Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2180-30.", "product_quantity": "141 bottles", "reason_for_recall": "Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.", "recall_initiation_date": "20200205", "center_classification_date": "20200213", "termination_date": "20210308", "report_date": "20200219", "code_info": "Lot #: CY0937, Exp 12/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0752-2020", "product_description": "MORPHINE 15MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@19 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201972"], "brand_name": ["OXYCODONE AND ACETAMINOPHEN"], "generic_name": ["OXYCODONE AND ACETAMINOPHEN"], "manufacturer_name": ["Aurolife Pharma, LLC"], "product_ndc": ["13107-043", "13107-044", "13107-045", "13107-046"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "OXYCODONE HYDROCHLORIDE"], "rxcui": ["1049214", "1049221", "1049225", "1049635"], "spl_id": ["369b6fef-c3e4-4a8c-ad28-7a9827caf0a6"], "spl_set_id": ["69df20d9-b1d5-47dc-9ff0-29987284f8c7"], "package_ndc": ["13107-043-30", "13107-043-01", "13107-043-05", "13107-043-99", "13107-044-30", "13107-044-01", "13107-044-05", "13107-044-99", "13107-045-30", "13107-045-01", "13107-045-05", "13107-045-99", "13107-046-30", "13107-046-01", "13107-046-05", "13107-046-99"], "is_original_packager": [true], "upc": ["0313107046018"], "unii": ["362O9ITL9D", "C1ENJ2TE6C"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1237-2020", "product_description": "Oxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-046-01", "product_quantity": "14707 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 046180056A, Exp. Date 05/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1208-2020", "product_description": "Naltrexone 4.5 mg/mL Suspension 30 mL bottle, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45177 Discard by: 9/4/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0732-2020", "product_description": "FENTANYL 5MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@14 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076921"], "brand_name": ["MIRTAZAPINE"], "generic_name": ["MIRTAZAPINE"], "manufacturer_name": ["Aurolife Pharma LLC"], "product_ndc": ["13107-001", "13107-031", "13107-003", "13107-032"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MIRTAZAPINE"], "rxcui": ["311725", "311726", "314111", "476809"], "spl_id": ["4329eeed-8071-4b6c-887d-0cd00647b84c"], "spl_set_id": ["aa05d606-29fd-443e-802b-1d65584d6bb1"], "package_ndc": ["13107-001-30", "13107-001-60", "13107-001-90", "13107-001-01", "13107-001-05", "13107-031-30", "13107-031-34", "13107-031-60", "13107-031-90", "13107-031-01", "13107-031-05", "13107-031-32", "13107-003-30", "13107-003-34", "13107-003-60", "13107-003-90", "13107-003-01", "13107-003-05", "13107-003-32", "13107-032-34", "13107-032-60", "13107-032-90", "13107-032-01", "13107-032-05", "13107-032-32"], "is_original_packager": [true], "unii": ["A051Q2099Q"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1235-2020", "product_description": "Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-031-34", "product_quantity": "56208 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 031180028A, Exp. Date 03/2021", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021540"], "brand_name": ["CADUET"], "generic_name": ["AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-2260", "0069-2150", "0069-2170", "0069-2190", "0069-2160", "0069-2180", "0069-2250", "0069-2270", "0069-6180", "0069-6323", "0069-6565", "0069-6747", "0069-7810", "0069-7232", "0069-7654", "0069-7476"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["404011", "404013", "597967", "597977", "597980", "597984", "597987", "597990", "750199", "750203", "750207", "750211", "750227", "750231", "750235", "750239"], "spl_id": ["1ce17020-050b-4fdc-8201-1a5648ca8a66"], "spl_set_id": ["6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6"], "package_ndc": ["0069-2150-30", "0069-2170-30", "0069-2190-30", "0069-2260-30", "0069-2160-30", "0069-2180-30", "0069-2250-30", "0069-2270-30", "0069-6180-30", "0069-6323-30", "0069-6565-30", "0069-6747-30", "0069-7810-30", "0069-7232-30", "0069-7654-30", "0069-7476-30"], "is_original_packager": [true], "upc": ["0300692150305", "0300692250302", "0300692170303", "0300692160304", "0300692190301", "0300696565303", "0300696747303", "0300697810303", "0300692270300", "0300697232303", "0300697476301", "0300696180308", "0300696323309", "0300692260301", "0300697654303"], "unii": ["864V2Q084H", "48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "84860", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0842-2020", "product_description": "Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/10 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2160-30.", "product_quantity": "128 bottles", "reason_for_recall": "Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.", "recall_initiation_date": "20200205", "center_classification_date": "20200213", "termination_date": "20210308", "report_date": "20200219", "code_info": "Lot #: CY0963, Exp 07/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Bolingbroke", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86270", "recalling_firm": "SG24 LLC", "address_1": "8315 Rivoli Road", "address_2": "Ste A", "postal_code": "31004", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1571-2020", "product_description": "SkinGuard 24 All-Day Hand Sanitizer 2.67 oz. bottle with foam pump, Dist by: SG24 LLC, Bolingbroke, GA 31004  UPC 793573147103", "product_quantity": "9600 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug", "recall_initiation_date": "20200814", "center_classification_date": "20200911", "termination_date": "20230605", "report_date": "20200909", "code_info": "SKU 051220024  All lots labeled to contain methanol"}, {"status": "Terminated", "city": "Barcelona", "state": "N/A", "country": "Spain", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85869", "recalling_firm": "Medichem S.A.", "address_1": "Fructuos Gelabert 6-8", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1534-2020", "product_description": "Chlorhexidine Gluconate 0012 For Manufacturing, Processing or Repacking, RX Only, Medichem, S.A. Poligono Industrial Celra, 17460, Celra, Girona (Spain/Espana); Fructuos Gelabert, 6-8, 08970, Sant Joan Despi, Barcelona (Spain/Espana)  NDC 53296-0012-0", "product_quantity": "117,800 kg", "reason_for_recall": "Microbial contamination of Non-Sterile Product; detection  of the gram-negative bacillus Serratia marcescens in certain API batches", "recall_initiation_date": "20200624", "center_classification_date": "20200821", "termination_date": "20210409", "report_date": "20200902", "code_info": "A-190571, exp. 11/29/21,  A-190418, exp. 09/04/21,  A-190503, exp. 10/25/21,  A-190576, exp. 12/02/21,  A-190537, exp. 11/15/21,  A-200082, exp. 02/24/22,  A-200085, exp. 02/25/22,  A-200097, exp. 03/05/22,  A-200116, exp. 03/13/22,  A-200127, exp. 03/19/22,  A-200131, exp. 03/20/22"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85169", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-1056-2020", "product_description": "Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.125mg/0.03mg, packaged in 1 Wallet of 28 Tablets (NDC 68180-857-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-857-13); Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.", "product_quantity": "9,897 cartons", "reason_for_recall": "Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity.", "recall_initiation_date": "20200309", "center_classification_date": "20200324", "termination_date": "20210525", "report_date": "20200318", "code_info": "Lot #: L800951, Exp July 2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0964-2020", "product_description": "Magnesium Chloride Injection, MAGNESIUM CHLORIDE  20% INJECTABLE, For IV Use, 50 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0225-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10292019+53156, Exp 4/26/2020; 11182019+53247, Exp 5/16/2020"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85224", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.", "recall_number": "D-1069-2020", "product_description": "Advil Liqui-Gel Mini 160+20+20 CT (e-commerce)  NDC # 0573-1715-59  SKU# F00573171559 (original lot # R53074)  Co-packaged Batch/Lot # 0198FR & 3188FRB", "product_quantity": "4,104 bottles", "reason_for_recall": "Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.", "recall_initiation_date": "20200316", "center_classification_date": "20200326", "termination_date": "20211028", "report_date": "20200401", "code_info": "Batch/Lot #   Lot # 0198FR, original lot # R53074, exp. date 10/31/2020  Lot # 3188FRB, original lot # R53074, exp. date 10/31/2020", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077691"], "brand_name": ["SIMVASTATIN"], "generic_name": ["SIMVASTATIN"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-050", "65862-051", "65862-052", "65862-053", "65862-054"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIMVASTATIN"], "rxcui": ["198211", "200345", "312961", "312962", "314231"], "spl_id": ["7aa9abed-6d40-4370-aeac-4d34e2cf0416"], "spl_set_id": ["4724dbb4-3613-4e6a-948f-a43d34f97f06"], "package_ndc": ["65862-050-30", "65862-050-45", "65862-050-90", "65862-050-01", "65862-050-00", "65862-050-99", "65862-050-26", "65862-051-30", "65862-051-45", "65862-051-90", "65862-051-01", "65862-051-00", "65862-051-99", "65862-051-26", "65862-052-30", "65862-052-45", "65862-052-90", "65862-052-01", "65862-052-00", "65862-052-99", "65862-052-26", "65862-053-30", "65862-053-45", "65862-053-90", "65862-053-01", "65862-053-00", "65862-053-99", "65862-053-22", "65862-054-30", "65862-054-45", "65862-054-90", "65862-054-00", "65862-054-99", "65862-054-39"], "is_original_packager": [true], "nui": ["N0000175589", "N0000000121"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "unii": ["AGG2FN16EV"]}, "product_type": "Drugs", "event_id": "85183", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1234-2020", "product_description": "Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90", "product_quantity": "26976 units", "reason_for_recall": "CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed", "recall_initiation_date": "20200318", "center_classification_date": "20200413", "termination_date": "20240325", "report_date": "20200422", "code_info": "Lot #: 05319004A1, Exp. Date 03/2022", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090624"], "brand_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "generic_name": ["SULFAMETHOXAZOLE AND TRIMETHOPRIM"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-419", "65862-420"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SULFAMETHOXAZOLE", "TRIMETHOPRIM"], "rxcui": ["198334", "198335"], "spl_id": ["e4ea8e99-58d4-4c1b-b84c-db0838610059"], "spl_set_id": ["284b5dac-2b8d-46bf-95fe-80ce03fa178a"], "package_ndc": ["65862-419-20", "65862-419-01", "65862-419-05", "65862-419-99", "65862-420-20", "65862-420-01", "65862-420-05", "65862-420-99"], "is_original_packager": [true], "nui": ["N0000175489", "N0000000191", "N0000187062", "N0000187061", "N0000175504", "M0020790", "N0000185504"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antibacterial [EPC]", "Sulfonamide Antimicrobial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "pharm_class_cs": ["Sulfonamides [CS]"], "unii": ["AN164J8Y0X", "JE42381TNV"]}, "product_type": "Drugs", "event_id": "86190", "recalling_firm": "Aurobindo Pharma USA Inc.", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1535-2020", "product_description": "Sulfamethoxazole and Trimethoprim Tablets, USP, 800 mg/160 mg Double Strength, 500 Tablets per bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC: 65862-420-05.", "product_quantity": "5748 bottles", "reason_for_recall": "Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).", "recall_initiation_date": "20200810", "center_classification_date": "20200821", "termination_date": "20240628", "report_date": "20200902", "code_info": "Lot #s: STSD19109-A, Exp. 05/31/2022; SP1D19083AA3, SP1D19084AA3, Exp. 08/31/2022."}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1436-2020", "product_description": "Tadalafil 12 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "600 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-23-2020:62@14, BUD 7/21/2020  02-26-2020:56@14, BUD 8/24/2020"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 90"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313393", "1724437"], "spl_id": ["e3ca1f91-e647-489b-8b73-db375bff141e"], "spl_set_id": ["dac99035-9098-4710-bf55-c46889ffc282"], "package_ndc": ["42192-331-30", "42192-331-01", "42192-331-10"], "is_original_packager": [true], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "85721", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US and Puerto Rico", "recall_number": "D-1300-2020", "product_description": "NP Thyroid 90, Thyroid Tablets, USP, 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA  30005, NDC 42192-331-01.", "product_quantity": "49,128 bottles", "reason_for_recall": "Superpotent Drug.", "recall_initiation_date": "20200522", "center_classification_date": "20200608", "termination_date": "20220119", "report_date": "20200610", "code_info": "Lots: M331G18-1 Exp. JUN-2020, M331J18-1, M331J18-2, Exp.  AUG-2020, M331M18-1, M331M18-2 Exp. NOV-2020"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA075772"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6041", "0641-6043", "0641-6042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["25d6c438-45d2-4162-91c2-b5caa0f86bf3"], "spl_set_id": ["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"], "package_ndc": ["0641-6043-01", "0641-6043-25", "0641-6042-01", "0641-6042-25", "0641-6041-01", "0641-6041-25"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "84534", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0864-2020", "product_description": "Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25 vials/shelf-pack (NDC 0641-6042-25), For IV or IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.", "product_quantity": "101,710 25 vials/shelf-pack", "reason_for_recall": "Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)", "recall_initiation_date": "20191217", "center_classification_date": "20200302", "termination_date": "20210609", "report_date": "20200122", "code_info": "Lot #: 038366, Exp. Date Mar 2020; 048365, 048367, Exp. Date Apr 2020; 078301, 078303, Exp. Date July 2020; 118358, Exp. Date Nov 2020; 029353, Exp. Date Feb 2021; 019413, Exp. Date Jan 2021", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1437-2020", "product_description": "Tadalafil 18 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "900 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-23-2020:33@15, BUD 7/21/2020  02-07-2020:48@3, BUD 8/5/2020  02-26-2020:09@15, BUD 8/24/2020"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84798", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0831-2020", "product_description": "Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01", "product_quantity": "69,012 bottles", "reason_for_recall": "GMP Deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200127", "center_classification_date": "20200206", "termination_date": "20201210", "report_date": "20200212", "code_info": "Lot #: 1269726M, exp. date 01/2020; 1283269M, 1283270M, exp. date 03/2020; 1292992M,1292993A, exp. date 04/2020"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077321"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-512", "68180-513", "68180-517", "68180-980", "68180-981", "68180-982", "68180-979", "68180-514", "68180-515", "68180-516"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["6723a96d-02f8-40c2-95ec-89a7053a7117"], "spl_set_id": ["7d6c31e2-b5a4-4279-8013-a8dad37ea73b"], "package_ndc": ["68180-512-02", "68180-512-30", "68180-512-09", "68180-512-01", "68180-512-03", "68180-513-30", "68180-513-03", "68180-513-01", "68180-513-09", "68180-513-02", "68180-513-05", "68180-517-03", "68180-517-01", "68180-517-30", "68180-517-09", "68180-517-04", "68180-517-02", "68180-980-03", "68180-980-30", "68180-980-01", "68180-980-09", "68180-980-05", "68180-980-02", "68180-981-01", "68180-981-03", "68180-981-30", "68180-981-09", "68180-981-02", "68180-981-05", "68180-982-01", "68180-982-02", "68180-982-30", "68180-982-03", "68180-982-09", "68180-979-01", "68180-979-03", "68180-979-30", "68180-979-09", "68180-514-01", "68180-514-02", "68180-514-03", "68180-514-09", "68180-514-30", "68180-514-05", "68180-515-01", "68180-515-02", "68180-515-03", "68180-515-09", "68180-515-30", "68180-515-05", "68180-516-01", "68180-516-02", "68180-516-03", "68180-516-09", "68180-516-30"], "is_original_packager": [true], "upc": ["0368180513018", "0368180512028", "0368180513032"], "unii": ["E7199S1YWR"]}, "product_type": "Drugs", "event_id": "85770", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US.", "recall_number": "D-1290-2020", "product_description": "Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.", "product_quantity": "4,224 bottles", "reason_for_recall": "Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.", "recall_initiation_date": "20200528", "center_classification_date": "20200608", "termination_date": "20210504", "report_date": "20200617", "code_info": "Lot # Q900683, Exp. 10/31/2022"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1439-2020", "product_description": "Tadalafil 3 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "900 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-27-2020:93@21, BUD 7/25/2020"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:8CE1446,   8DE1740,   8FE1238,   8FE1794,   8GE1964,   8JE2159,   8ME2546,   8ME2547,   9BE3011,   9CE3854,   9DE3158,   9FE3340,   9HE3445,   9JE2663,   8AE1779,   8BE1414,   8DE1199,   8DE1200,   8DE1532,   8EE1321,   8FE1239,   8FE1346,   8FE1793,   8HE1516,   8KE2563,   8KE2563R,   8LE2260,   9AE2610,   9AE2612,   9BE3012,   9BE3013,   9CE3852,   9DE3156R,   9DE3160,   9DE3161,   9EE2952,   9FE3338,   9GE2993,   8AV1095,   8AV1150,   8AV1235,   8AV1236,   8AV1237,   8BV0896,   8BV0897,   8BV0910,   8BV1737,   8BV1757,   8BV1758,   8CV0930,   8CV1316,   8CV1317,   8CV1319,   8CV1324,   8CV1633,   8DV1128,   8DV1129,   8DV1134,   8EV0993,   8EV0994,   8EV0995,   8EV1240,   8FV0712,   8FV0912,   8FV0913,   8FV0914,    8FV0915,   8GV0847,   8GV0849,   8GV0997,   8HV0926,   8HV0928,   8HV1534,   8HV1535,   8JV0730,   8JV0944,   8KV2339,   8KV2348,   8KV2485,   8LV1791,   8LV2205,   8MV1650,   8MV1712,   9AV2395,   9AV2679,   9AV2680,   9BV2182,   9CV1345,   9CV1346,   9CV1347,   9CV1348,   9CV1349,   9DV1511,   9DV1515,   9EV1422,   9EV1585,   9EV1596,   9FV1132,   9FV1275R,   9FV1330,   9FV1331,   9FV1332,   9FV1333,   9FV1339,   9FV1954,   9FV1972,   9GV1675,   9GV1994,   9HV1415", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 95 tablets per bottle. [Brand, NDC] NDC Basic Care: 0113-7852-01; NDC Berkley Jensen: 68391-852-56; NDC: CVS Health: 59779-540-01; NDC DG Health: 55910-011-01; NDC Kirkland: 63981-852-56; NDC Kroger: 30142-600-56; NDC Meijer: 41250-852-01; NDC Rite Aid: 11822-0852-4; NDC Walgreens: 0363-0852-01", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1026-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84516", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Natiowide", "recall_number": "D-0641-2020", "product_description": "Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India   Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ   NDC 68462-249-30", "product_quantity": "98,988 bottles", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20191217", "center_classification_date": "20200105", "report_date": "20200115", "code_info": "7701429A  7701522A  7702255A  7704745A  19190456  19190472  19190490"}, {"status": "Terminated", "city": "Rockland", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021197"], "brand_name": ["CETROTIDE"], "generic_name": ["CETRORELIX ACETATE"], "manufacturer_name": ["EMD Serono, Inc."], "product_ndc": ["44087-1225"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "rxcui": ["283402", "284441"], "spl_id": ["716029d9-4462-4732-846c-456e74363b83"], "spl_set_id": ["aca7768e-28a7-4027-b1d8-e66247665f79"], "package_ndc": ["44087-1225-1"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "85938", "recalling_firm": "EMD Serono, Inc.", "address_1": "1 Technology Pl", "address_2": "", "postal_code": "02370-1071", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1379-2020", "product_description": "Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1", "product_quantity": "30,756 vials", "reason_for_recall": "Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.", "recall_initiation_date": "20200629", "center_classification_date": "20200708", "termination_date": "20220311", "report_date": "20200715", "code_info": "Lot # 8J025A; 8J025B, Exp 09/30/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Lambertville", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210733"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-860", "64380-861"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312529", "628953"], "spl_id": ["a74390de-64e9-482d-8630-d1a2452324fe"], "spl_set_id": ["0224e5b3-3c49-4e6e-aa78-1abcc6969246"], "package_ndc": ["64380-860-06", "64380-860-07", "64380-860-08", "64380-861-06", "64380-861-07", "64380-861-08"], "is_original_packager": [true], "upc": ["0364380861065", "0364380860068"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "86283", "recalling_firm": "Strides Inc.", "address_1": "201 S Main St Ste 3", "address_2": "N/A", "postal_code": "08530-1859", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0001-2021", "product_description": "Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP  8mEq  (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Brunswick NJ 08816     NDC 64380-860-06", "product_quantity": "11,280 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20200824", "center_classification_date": "20201001", "termination_date": "20220111", "report_date": "20201007", "code_info": "7240675A; Exp. 12/31/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0747-2020", "product_description": "HYDROMORPHONE 6MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@9 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1134-2020", "product_description": "Herpes Soap, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-  0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0978-2020", "product_description": "Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 20 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0336-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10082019+53069, Exp 2/28/2020"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0700-2020", "product_description": "BUP 30MG/ HYDROM 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@23 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85169", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-1055-2020", "product_description": "Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.", "product_quantity": "1,712 cartons", "reason_for_recall": "Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.", "recall_initiation_date": "20200309", "center_classification_date": "20200324", "termination_date": "20210525", "report_date": "20200318", "code_info": "Lot #: L800915, Exp July 2020", "more_code_info": ""}, {"country": "United States", "city": "Berlin", "address_1": "15 Massirio Dr Ste 201", "reason_for_recall": "CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.", "address_2": "", "product_quantity": "11, 250 bottles", "code_info": "Lot #: a) 81253, 81272, Exp. Date 01/2021 and b) 81268, Exp. Date 01/2021", "center_classification_date": "20200323", "distribution_pattern": "Product was distributed nationwide within the United States.", "state": "CT", "product_description": "Solifenacin Succinate Tablets, 10 mg, packaged in a) 30-count bottles (NDC 51991-894-33) and b) 90-count bottles (NDC 51991-894-90),  Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487; Manufactured by: Piramal Enterprises Limited Plot No 67-70, Sector -2 Pithampur 454 775, Dist, Dhar Madhya Pradesh, INDIA", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Breckenridge Pharmaceutical, Inc", "recall_number": "D-1051-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85186", "termination_date": "20201019", "more_code_info": "", "recall_initiation_date": "20200124", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0679-2020", "product_description": "BPC-157 2000 mcg/mL in 5 mL vials Assurance Infusion (713) 533-8800", "product_quantity": "28 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 11132019@15 Exp. 02/11/2020; 12112019@25 Exp. 02/13/2020; 11202019@9 Exp. 02/13/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85880", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two medical clinics located in FL.", "recall_number": "D-1364-2020", "product_description": "Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc., Farmingdale, NY, Preferred Pharmaceuticals, Anaheim, CA NDC: 68788-6932-01", "product_quantity": "144 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.", "recall_initiation_date": "20200617", "center_classification_date": "20200626", "termination_date": "20240321", "report_date": "20200708", "code_info": "J0119M, K1419L, K2719J, A0220H; Exp. Date 12/2020"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84848", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0834-2020", "product_description": "Ethacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-246-01.", "product_quantity": "2207 Vials", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20200131", "center_classification_date": "20200210", "termination_date": "20211026", "report_date": "20200219", "code_info": "Lot #s: M804062, Exp. 01/2020; M804063, M804064, Exp. 02/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076931"], "brand_name": ["BUPRENORPHINE HYDROCHLORIDE"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9246"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["238129"], "spl_id": ["8ba9787c-d429-4a5d-8424-e13be15cb9f1"], "spl_set_id": ["adc1167e-910e-4d7b-abdc-751d3df0c3dc"], "package_ndc": ["0143-9246-01", "0143-9246-05"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "86243", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "N/A", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1533-2020", "product_description": "Buprenorphine HCl Injection, 0.3 mg/mL, 1 mL vial, For Intramuscular or Intravenous Use Only, Rx Only, Manufactured by: Hikma Farmaceutica, Portugal S.A., Distributed by: Hikma Pharmaceuticals, Eatontown, NJ 07724, USA Inc., NDC: 0143-9246-01.", "product_quantity": "97,890 vials", "reason_for_recall": "Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.", "recall_initiation_date": "20200814", "center_classification_date": "20200821", "termination_date": "20210610", "report_date": "20200902", "code_info": "Lot #s: 2005023.1, 2005024.1, 2005025.1, Exp 02/28/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0979-2020", "product_description": "Iohexol (PF) Injection,OMNIPAQUE INJECTION [5ML] 300MG I/ML INJECTABLE, For IA Use, 5 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1413-5", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10012019+52984, Exp 1/19/2020"}, {"status": "Terminated", "city": "Atizapan De Zaragoza", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86172", "recalling_firm": "ROQUE PLAST, S.A. DE C.V.", "address_1": "Cerrada Adolfo Manfredi 7 C", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1559-2020", "product_description": "Command Brands GelAnti Bac Instant Hand Sanitizer, 70% Alcohol, , 8 FL OZ 250mL bottle, Roqueplast S.A. de C.V. Cda. Adolfo Manfredi #7 Altizapan de Zaragoza CP 52958 Edo de Mexico UPC 8 52239 00689 2", "product_quantity": "311,038 bottles", "reason_for_recall": "CGMP Deviation: Potential contamination with undeclared methanol.", "recall_initiation_date": "20200804", "center_classification_date": "20200831", "termination_date": "20220208", "report_date": "20200909", "code_info": "Lots: 200371-12 Exp. 12/17/2023, 200371OH-05 Exp. 12/17/2023, 170420OH-06 Exp. 04/17/2023, 170420OH-8 Exp. 12/17/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1612-2020", "product_description": "WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 Tablets, NDC 64727-6150-4; c) 60 Tablets, NDC 64727-6150-5; d) 90 Tablets, NDC 64727-6150-6; e) 100 Tablets, NDC 64727-6150-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0716-2020", "product_description": "BUP 675MCG/MORP 20MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12122019@12 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077272"], "brand_name": ["CARBAMAZEPINE"], "generic_name": ["CARBAMAZEPINE"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-268", "13668-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBAMAZEPINE"], "rxcui": ["308973", "308979"], "spl_id": ["2b305f64-7c1a-4cf6-a4ad-57326eb4c874"], "spl_set_id": ["97e6e175-75e8-437b-b457-ddb1ae4e857d"], "package_ndc": ["13668-268-30", "13668-268-01", "13668-268-10", "13668-268-31", "13668-268-05", "13668-271-01", "13668-271-10", "13668-271-49", "13668-271-05"], "is_original_packager": [true], "upc": ["0313668268300"], "nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "unii": ["33CM23913M"]}, "product_type": "Drugs", "event_id": "85644", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1317-2020", "product_description": "Carbamazepine Tablets, USP 200 mg, packaged in a 500-count bottle, Rx only, Manufactured by: Torrent Pharmaceuticals Ltd, Bharuch 392130, India; Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-268-05", "product_quantity": "6228 Bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20200511", "center_classification_date": "20200618", "termination_date": "20220810", "report_date": "20200610", "code_info": "Lot #:  4FF4F001, Exp 1/2023"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090295"], "brand_name": ["METFORMIN HYDROCHLORIDE EXTENDED RELEASE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."], "product_ndc": ["72789-009"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975"], "spl_id": ["3143f509-5529-ee8b-e063-6294a90aeed3"], "spl_set_id": ["14f3091c-f243-4364-b433-727c7d4ef8d5"], "package_ndc": ["72789-009-30", "72789-009-60", "72789-009-90", "72789-009-93", "49483-0623-01"], "original_packager_product_ndc": ["49483-623"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85828", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "N/A", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "United States.", "recall_number": "D-1333-2020", "product_description": "metFORMIN HCL ER 500 mg, a) 30 tablets (NDC 72789-009-30); b) 60 tablets (NDC 72789-009-60); c) 90 tablets (NDC 72789-009-90); d) 180 tablets (NDC 72789-009-93); e) 100 tablets (NDC 49483-0623-01)  bottles, Rx only PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127", "product_quantity": "1969 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200605", "center_classification_date": "20200620", "termination_date": "20211108", "report_date": "20200701", "code_info": "Lots:  a) A20B02, I19D03, J19A98, K19E32, L19C86 Exp. 12/31/2020;     b) I19D55, I19F50, K19A18, K19D87, L19B34, L19D23, L19E74 Exp. 12/31/2020;     c) I19E91, I19F33, J19B88, J19E70, K19D26, L19A65 Exp. 12/31/2020;     d) I19C21 Exp. 08/21/2020, I19C57, J19C21, J19C67, K19B53, L19C77, L19E44 Exp. 12/31/2020;     e) XP9004 Exp. 12/31/2020"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1162-2020", "product_description": "Sperm Booster, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0765-2020", "product_description": "QUADMIX FORTE in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 08132019@15 Exp. 02/09/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Polepally, Jadcherla", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA210931"], "brand_name": ["BUSULFAN"], "generic_name": ["BUSULFAN"], "manufacturer_name": ["Armas Pharmaceuticals Inc."], "product_ndc": ["72485-210"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["BUSULFAN"], "rxcui": ["253113"], "spl_id": ["ae29e15b-df07-403f-8d07-f99e3ce501e7"], "spl_set_id": ["4049d57f-342e-4233-8292-fed6b8f128ec"], "package_ndc": ["72485-210-01", "72485-210-08"], "is_original_packager": [true], "upc": ["0372485210015"], "nui": ["N0000000236", "N0000175558"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "unii": ["G1LN9045DK"]}, "product_type": "Drugs", "event_id": "86749", "recalling_firm": "Shilpa Medicare Limited", "address_1": "S-20 To S-26,  Pharm. Formulation Sez", "address_2": "Tsiic, Green Industrial Park", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0121-2021", "product_description": "Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single Dose Vial, Sterile, Cytotoxic Agent, Rx Only, 10 mL vial, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals, Inc., Manalapan, NJ 07726, Vial NDC 72485-210-01, Carton NDC 72485-210-08.", "product_quantity": "2,064 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20201208", "center_classification_date": "20201209", "termination_date": "20220311", "report_date": "20201216", "code_info": "Lot #: 7S10008B, Exp. 12/31/2020"}, {"status": "Terminated", "city": "Cleveland", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85217", "recalling_firm": "Medical Center Pharmacy, Inc.", "address_1": "2401 N Ocoee St", "address_2": "N/A", "postal_code": "37311-3853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Specific prescriptions to patients in TN", "recall_number": "D-1077-2020", "product_description": "*Mitomycin 0.04% Ophth DR eye drops, 5 mL bottle, Rx only,  Medical Center Pharmacy, 2401 N. Ocoee Street, Cleveland, TN 37311, NDC 67457-0518-05.", "product_quantity": "2 bottles", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20200313", "center_classification_date": "20200401", "termination_date": "20221014", "report_date": "20200408", "code_info": "Lot: 03022020@5 BUD: 03/16/2020"}, {"status": "Terminated", "city": "Celaya", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86858", "recalling_firm": "Simex Logistics SA de CV", "address_1": "Calle Salvatierra Fracc. El Puente 101", "address_2": "Col. Santa Maria, Celaya", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, GA, NV, TX", "recall_number": "D-0162-2021", "product_description": "Health & Hand Gel Hand Sanitizer 70% Alcohol Content, 33.8 FL OZ (1L), Distributed By Blue Ridge Southern Supply, LLC 1130 Ada St. Blue Ridge, GA 30513 Produced By: Simex Logistics S.A. de C.V. Salvatierra No. 101 Fracc. El Puente C.P. 38040 Celaya, Guanajuato, Mexico. smxcontact@simex-logistics.com Barcode: 6 18149 21988 9", "product_quantity": "19008 bottles", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20201125", "center_classification_date": "20201216", "termination_date": "20230517", "report_date": "20201223", "code_info": "Lot: 0-720, Exp 05/16/2023"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1615-2020", "product_description": "Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 90-count bottles (NDC  64727-3299-6), b) 100-count bottles (NDC 64727-3299-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: FDA analysis found product to be subpotent", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "Lot #: 099186, Exp. Date 11/2022"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1197-2020", "product_description": "Bi-Est 8:2/Progesterone 2.5 mg/150/mL Cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44908 Discard by: 6/17/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85018", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within United States and Puerto Rico", "recall_number": "D-0859-2020", "product_description": "Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by:  Akorn, Inc., Lake Forest, IL 60045.  NDC 17478-622-35", "product_quantity": "720 tubes", "reason_for_recall": "Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.", "recall_initiation_date": "20200221", "center_classification_date": "20200227", "termination_date": "20220728", "report_date": "20200304", "code_info": "Lot #: 8B66A, Exp. Date 01/2021; Lot 8C91A, Exp. Date  02/2021; Lots 8F07A, 8F16A, Exp. Date 05/2021; Lot 8F13A, Exp. Date 07/2021."}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86129", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1497-2020", "product_description": "Clobetasol Propionate Cream, USP, 0.05%, packaged in a)15g Tubes (NDC 60429-902-15) and b) 45g Tubes (NDC 60429-902-45), Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada, Marketed by: Golden State Medical Supply Inc. Camarillo, CA 93012.", "product_quantity": "N/A", "reason_for_recall": "Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.", "recall_initiation_date": "20200724", "center_classification_date": "20200813", "termination_date": "20201210", "report_date": "20200819", "code_info": "Lot #: a) AB28535, Exp. Date: Dec. 2021  b) AB40178, Exp. Date: Dec. 2021"}, {"status": "Terminated", "city": "Salisbury", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85752", "recalling_firm": "Jubilant Cadista Pharmaceuticals, Inc.", "address_1": "207 Kiley Dr", "address_2": "N/A", "postal_code": "21801-2249", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TN", "recall_number": "D-1281-2020", "product_description": "Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.", "product_quantity": "1,313,333 tablets", "reason_for_recall": "Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.", "recall_initiation_date": "20200526", "center_classification_date": "20200529", "termination_date": "20221115", "report_date": "20200603", "code_info": "Lot #s 19P0437 & 19P0438, Exp. 09/30/2021."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0727-2020", "product_description": "FENT 900MCG/SUF 210MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@3 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1159-2020", "product_description": "Skin Lift, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0737-2020", "product_description": "HYDROM 10MG/SUF 200MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@4 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1426-2020", "product_description": "Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "1200 capsules", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-16-2020:70@11, BUD 7/14/2020  01-30-2020:87@9, BUD 7/28/2020"}, {"status": "Terminated", "city": "East Haven", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86579", "recalling_firm": "Milbar Laboratories, Inc.", "address_1": "20 Commerce St", "address_2": "N/A", "postal_code": "06512-4145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico and internationally.", "recall_number": "D-0086-2021", "product_description": "DCL SA Scalp Therapy Shampoo (Salicylic Acid 3%) 300 ml/10.1 fl.oz. Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA, UPC 357486503120", "product_quantity": "1,815 bottles", "reason_for_recall": "GMP Deviations", "recall_initiation_date": "20201009", "center_classification_date": "20201117", "termination_date": "20230104", "report_date": "20201125", "code_info": "Lot #: KV092-3, Exp. Date Nov-21  Lot #: FX456-7, Exp. Date Jun-23"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0701-2020", "product_description": "BUP 30MG/ MORP 8MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@11 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85955", "recalling_firm": "WALKER EMULSIONS INC", "address_1": "4401 Se Johnson Creek Blvd", "address_2": "N/A", "postal_code": "97222-9218", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Distribution: Product distributed to sister plant site located in SC, and one donation made to consignee located in OR. Majority of hand sanitizer shipped to Canada (Health Canada has already received consignee information and classified the recall).", "recall_number": "D-1417-2020", "product_description": "Walker Hand Sanitizer, Non-Sterile Solution, Alcohol Antiseptic, 70%, 32 oz and 16 oz, Topical Solution, Walker Emulsions Inc., 4401 SE Johnson Creek Blvd., Portland, OR 97222, NDC 74940-0415-1", "product_quantity": "N/A", "reason_for_recall": "Incorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.", "recall_initiation_date": "20200603", "center_classification_date": "20200728", "termination_date": "20240513", "report_date": "20200729", "code_info": "Lot # 210061", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1602-2020", "product_description": "Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 mcg], 2 Grain (130 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3308-4; b) 60-count bottles, NDC 64727-3308-5; c) 90-count bottles, NDC 64727-3308-6; d) 100-count bottles, NDC 64727-3308-1; and e)  1,000-count bottles, NDC 64727-3308-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Ridgefield", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86527", "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "address_1": "900 Ridgebury Rd", "address_2": "N/A", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico", "recall_number": "D-0053-2021", "product_description": "Catapres (clonidine hydrochloride, USP)  0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01", "product_quantity": "N/A", "reason_for_recall": "An extraneous peak was observed for dissolution testing.", "recall_initiation_date": "20201005", "center_classification_date": "20201026", "termination_date": "20210929", "report_date": "20201104", "code_info": "Lot # 954953, EXP Jan 2022"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.", "address_2": "", "product_quantity": "", "code_info": "Lots:  8CE1429,   8CE1760,   9BE2907,   9DE3183,   9EE2900,   9JE2936", "center_classification_date": "20200313", "distribution_pattern": "Nationwide USA", "state": "MI", "product_description": "Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [NDC: Brand] NDC Good Sense:0113-0852-51; NDC Walgreens 0363-0852-51", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Perrigo Company PLC", "recall_number": "D-1017-2020", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "84127", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191023", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076772"], "brand_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "generic_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["62037-725", "62037-734", "62037-726", "62037-727"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHYLPHENIDATE HYDROCHLORIDE"], "rxcui": ["1091155", "1091170", "1091185", "1091210"], "spl_id": ["89caac38-0ada-4326-8b3e-65f0d23cbb1b"], "spl_set_id": ["85ef422d-af27-4126-9841-6892af1871d6"], "package_ndc": ["62037-725-01", "62037-734-01", "62037-726-01", "62037-727-01"], "is_original_packager": [true], "upc": ["0362037726019", "0362037734014", "0362037727016", "0362037725012"], "unii": ["4B3SC438HI"]}, "product_type": "Drugs", "event_id": "84797", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0836-2020", "product_description": "Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01", "product_quantity": "", "reason_for_recall": "CGMP deviations: Product bottle may be absent of desiccant.", "recall_initiation_date": "20200127", "center_classification_date": "20200210", "termination_date": "20201103", "report_date": "20200219", "code_info": "Lot #: 1332796 A, Exp 11/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075784"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-161", "63323-162"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ab476c4c-2c72-47b1-bf42-7a89703b0dd4"], "spl_set_id": ["d1920335-8e45-4960-b6e9-e6f1f9e6820c"], "package_ndc": ["63323-161-00", "63323-161-01", "63323-162-11", "63323-162-51", "63323-162-00", "63323-162-01", "63323-162-03", "63323-162-02"], "is_original_packager": [true], "upc": ["0363323162115", "0363323161002", "0363323162009", "0363323162030"], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "85504", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "USA Nationwide and Puerto Rico", "recall_number": "D-1297-2020", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC 63323-162-03), 25 x 2 mL Single Dose Vials per tray (NDC 63323-162-02); For IM use only, Not for IV use, Rx only, Fresenius Kabi, Lake Zurich, IL  60047.", "product_quantity": "3,497,575 vials", "reason_for_recall": "Presence of Particulate Matter - found in reserve sample vials at the firm.", "recall_initiation_date": "20200420", "center_classification_date": "20200608", "termination_date": "20231016", "report_date": "20200617", "code_info": "Lot #: 6119229, 6119273, Exp 06/2020; 6119843, Exp 09/2020; 6121115, Exp 02/2021; 6121451, 6121452, 6121496, Exp 03/2021"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M001"], "brand_name": ["GAVISCON"], "generic_name": ["ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE"], "manufacturer_name": ["Haleon US Holdings LLC"], "product_ndc": ["0135-0094", "0135-0095", "0135-0574"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ALUMINUM HYDROXIDE", "MAGNESIUM CARBONATE"], "rxcui": ["245001", "252203", "404472", "1251365"], "spl_id": ["4cfa1b72-26c3-495b-9d5a-2026d6b82def"], "spl_set_id": ["2d74e5bc-1f10-4fb6-9258-cd906e360013"], "package_ndc": ["0135-0094-41", "0135-0094-42", "0135-0095-41", "0135-0574-01"], "is_original_packager": [true], "unii": ["0E53J927NA", "5QB0T2IUN0"]}, "product_type": "Drugs", "event_id": "85755", "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings", "address_1": "184 Liberty Corner Rd", "address_2": "", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1325-2020", "product_description": "Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41", "product_quantity": "1,631,700 bottles  & 27,300 Twin-Pack botles", "reason_for_recall": "Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.", "recall_initiation_date": "20200528", "center_classification_date": "20200618", "termination_date": "20220124", "report_date": "20200624", "code_info": "Lot #: 0A21C1, Exp 12/31/2021; 0A31C1, Exp 12/31/2021; 0B05C1, Exp 12/31/2021; 8J04C1, Exp 7/31/2020; 8L05C1, Exp 9/30/200; 8L13C1 , Exp 10/31/2020; 9A14C1, Exp 12/31/2020; 9A21C1, Exp 12/31/2020; 9B04C1, Exp 12/31/2020; 9B11C1, Exp 1/31/2021; 9C04C1, Exp 1/31/2021; 9C12C1, Exp 2/28/2021; 9C25C1, Exp 2/28/2021; 9D17C1, Exp 3/312021; 9D24C1, Exp 3/312021; 9E01C1, Exp 3/31/2021; 9E10C1, Exp 3/31/2021; 9E21C1, Exp 4/30/2021; 9F11C1, Exp 5/31/2021; 9G15C1, Exp 6/30/2021; 9G30C1, Exp 6/30/2021; 9H06C1, Exp 6/30/2021; 9H12C1, Exp 7/31/2021, 9H2OC1, Exp 7/31/2021; 9H26C1, Exp 7/31/2021; 9J23C1, Exp 8/31/2021; 9J3OC1, Exp 8/31/2021; 9K08C1, Exp 8/31/2021; 9L11C1, Exp 10/31/2021; 9L18C1, Exp 10/31/2021; 9M02C1, Exp 10/31/2021; 9M09C1, Exp 11/30/2021; 9M17C1, Exp 11/30/2021; 19N1587221, Exp 7/31/2020; 19N1743754, Exp 12/31/2020; 19N1948440, Exp 6/30/2021; 19N1958219, Exp 6/30/2021; 20N2019997, Exp 7/31/2021; 20N2026258, Exp 8/31/2021; 20N2057778, Exp 8/31/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0763-2020", "product_description": "QUADMIX in 1 mL vial Assurance Infusion (713)-533-8800", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 07012019@30 Exp. 12/28/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0968-2020", "product_description": "Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIV [10ML] CMC 40MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0623-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 09042019+52874, Exp 3/2/2020"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1224-2020", "product_description": "Testosterone w/Cosmetic HRT Base 20 mg (2%) Cream 30 GM jar, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 jar", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Unknown", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1481-2020", "product_description": "Goodness Gurus, Healthy Hemp Drops, 1500 MG/Spearmint, 1 FL. OZ bottles, Distributed by: Goodness Gurus, Inc., Carlisle, PA, UPC 6 53341 99411 0", "product_quantity": "50 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003237", "more_code_info": ""}, {"status": "Terminated", "city": "Orchard Park", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M022"], "brand_name": ["RED CROSS ORAL PAIN RELIEF"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["The Mentholatum Company"], "product_ndc": ["10742-8902"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["308657"], "spl_id": ["2979d20c-f97b-246c-e063-6294a90a2df5"], "spl_set_id": ["cbd41429-f730-4577-9f06-ef1831cf62e1"], "package_ndc": ["10742-8902-1"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"], "upc": ["310742095098"]}, "product_type": "Drugs", "event_id": "86154", "recalling_firm": "The Mentholatum Company", "address_1": "707 Sterling Dr", "address_2": "N/A", "postal_code": "14127-1557", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1541-2020", "product_description": "Red Cross Oral Pain (Oral Anesthetic benzocaine 20%), Maximum Strength, 1/8 Fl. Oz. (3.7 mL) bottle with Cotton Pellets box packaged in a blister pack, Distributed by: Mentholatum Company, Orchard Park, NY 14127 NDC 10742-8902-1, UPC 3 10742 09509 8", "product_quantity": "31,732 Blister Packs", "reason_for_recall": "Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains \"Natural Eugenol Oil\" in which it does not.", "recall_initiation_date": "20200731", "center_classification_date": "20200824", "termination_date": "20220520", "report_date": "20200902", "code_info": "Item Number:  95090007  Lot #: 66572"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1393-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 90 count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC  53746-0178-90", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HB10019A 03-2021  HB10119A 03-2021  HB10219A 03-2021  HB10319A 03-2021  HD02119A 04-2021  HD03319A 04-2021  HF09118A 06-2020  HF11618A 06-2020  HF15218A 07-2020  HF15318A 07-2020  HJ01418A 09-2020  HJ01518A 09-2020  HJ01618A 09-2020  HJ01718A 09-2020  HJ04718A 09-2020  HK03218A 10-2020  HK03318A 10-2020  HK03418A 10-2020  HK03518A 10-2020  HK03618A 10-2020  HK13718A 11-2020  HK13818A 11-2020  HK13918A 11-2020  HK14018A 11-2020  HK14118A 11-2020  HK14218A 11-2020  HK14318A 11-2020  HK14418A 11-2020  HK14518A 11-2020  HM00118A 11-2020"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85232", "recalling_firm": "Y-O Management LLC, dba Natural Remedy Store", "address_1": "713 Sw Military Dr", "address_2": "N/A", "postal_code": "78221", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed in GA and TX", "recall_number": "D-1080-2020", "product_description": "Natural Remedies Active Male 500 mg Male Pleasure Formula Dietary Supplement Manufactured For: Natural Remedies San Antonio, TX, USA 1(877)543-3501", "product_quantity": "19156 packets estimated distributed", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction", "recall_initiation_date": "20200316", "center_classification_date": "20200404", "termination_date": "20211110", "report_date": "20200408", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1211-2020", "product_description": "Hydrocortisone 2.5%/Econazole 1% 50/50 Using Powder 25%/1% Cream 60 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45212 Discard by: 9/9/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Coyotepec", "state": "", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86063", "recalling_firm": "Maquiladora Miniara Sa De Cv", "address_1": "Crta. Teoloyucan Huehuetoca Km. 22", "address_2": "Coyotepec", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1565-2020", "product_description": "Shine & Clean Hand Sanitizer gel, (Ethyl Alcohol 70%), 33.81 fl oz (1L) bottle, Made in Mexico By: Maquiladora Miniara S.A. de C.V. Carrerera Teoloyucan Huehuetoca km: 22 S/N La Planada Mexico C.P.: 54665 NDC 76753-001-01", "product_quantity": "245,500 bottles", "reason_for_recall": "CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.", "recall_initiation_date": "20200709", "center_classification_date": "20200910", "termination_date": "20240424", "report_date": "20200916", "code_info": "Lots: F200829088, F200829095, F200829107, D202728743, D202528742, D202428733, D202728743, D2028753, D202528742, D202428733, D202028689, D201828660, D202428734, E200128784, E200418795,   D202428734, D202828689, D201828660, E201628912, E201628913, E201628911, E201528902, E201528903, E201628910, E201628918, E201628914, E201628915, E201628916, E201628917, E202328969, E202428975, E202528981, E202128947, E201728918, E201728919, E201428876,  E201828894, E201828920, E201428876, E201128850, E201328859, E200628817, E200828826, E200928840, D202128699, D202428700.", "more_code_info": ""}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "84620", "recalling_firm": "Idelle Labs", "address_1": "One Helen Of Troy Plaza", "address_2": "N/A", "postal_code": "79912", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0784-2020", "product_description": "SURE 48hr Confidence Nourishing Coconut invisible solid Antiperspirant & Deodorant Net Wt 2.6 oz (73g) NDC# 41595-5547-1 UPC 8 83484 31020 5   Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912", "product_quantity": "Unknown", "reason_for_recall": "Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.", "recall_initiation_date": "20191120", "center_classification_date": "20200116", "termination_date": "20220928", "report_date": "20200115", "code_info": "Lot: 19277K1"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078596"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-178", "65162-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["984302ad-793e-4f35-92da-e5e7f92154f6"], "spl_set_id": ["c01a79e0-f2b7-4d99-857e-bda7f24fe319"], "package_ndc": ["65162-178-89", "65162-178-03", "65162-178-09", "65162-178-10", "65162-178-50", "65162-178-11", "65162-179-03", "65162-179-09", "65162-179-10", "65162-179-50"], "is_original_packager": [true], "upc": ["0365162178104", "0365162179101"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1347-2020", "product_description": "amneal Metformin Hydrochloride Extended-release Tablets, USP, 500 mg Rx only, 100 Tablets bottles, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Ahmedabad 382213 India Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807   NDC 65162-178-10", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "AM181118AA 10/31/2020  AM181191AA 9/30/2020  AM181192AA 9/30/2020  AM181235AA 9/30/2020  AM181236AA 9/30/2020  AM181237AA 9/30/2020  AM181240AA 9/30/2020  AM181241AA 9/30/2020  AM181242AA 9/30/2020  AM181243AA 9/30/2020  AM181244AA 10/31/2020  AM181268AA 10/31/2020  AM181269AA 10/31/2020  AM181270AA 10/30/2020  AM181271AA 10/31/2020  AM181272AA 10/31/2020  AM181273AA 10/31/2020  AM181274AA 10/31/2020  AM181275AA 10/31/2020  AM181276AA 10/31/2020  AM181277AA 10/31/2020  AM181307AA 10/31/2020  AM181308AA 10/31/2020  AM181309AA 10/31/2020  AM181310AA 10/31/2020  AM181311AA 10/31/2020  AM181313AA 10/31/2020  AM181314AA 10/31/2020  AM181315AA 11/30/2020  AM181316AA 11/30/2020  AM181317AA 12/31/2020  AM181419AA 11/30/2020  AM181420AA 11/30/2020  AM181421AA 11/30/2020  AM181422AA 11/30/2020  AM181423AA 11/30/2020  AM181424AA 11/30/2020  AM181425AA 11/30/2020  AM181430BA 12/31/2020  AM181455AA 12/31/2020  AM181456AA 12/31/2020  AM181457AA 12/31/2020  AM181458AA 12/31/2020  AM181459AA 12/31/2020  AM181460AA 12/31/2020  AM181461AA 12/31/2020  AM181462AA 12/31/2020  AM181463AA 12/31/2020  AM181464AA 12/31/2020  AM181465AA 12/31/2020  AM190054AA 12/31/2020  AM190055AA 12/31/2020  AM190057AA 12/31/2020  AM190058AA 12/31/2020  AM190102AA 12/31/2020  AM190103AA 12/31/2020  AM190104AA 12/31/2020  AM190105AA 12/31/2020  AM190106AA 12/31/2020  AM190107AA 12/31/2020  AM190108AA 12/31/2020  AM190120AA 12/31/2020  AM190633AA 5/31/2021  AM190634AA 5/31/2021  AM190635AA 5/31/2021  AM190636AA 5/31/2021  AM190637AA 5/31/2021  AM190638AA 5/31/2021  AM190640AA 5/31/2021  AM190641AA 5/31/2021  AM190642AA 5/31/2021  AM190664AA 5/31/2021  AM190665AA 5/31/2021  AM190666AA 5/31/2021  AM190667AA 5/31/2021  AM190668AA 5/31/2021  AM190669AA 6/30/2021  AM190670AA 6/30/2021  AM190671AA 6/30/2021  AM190672AA 6/30/2021  AM190714AA 6/30/2021  AM190934A 8/31/2021  AM190991A 8/31/2021  AM190992A 8/31/2021  AM190993A 8/31/2021  AM190994A 8/31/2021  AM191040A 9/30/2021  AM191041A 9/30/2021  AM191083A 9/30/2021  AM191084A 9/30/2021  AM191085A 9/30/2021  AM191091A 9/30/2021  AM191092A 9/30/2021  AM191105A 9/30/2021  AM191106A 10/31/2021  AM191107A 10/31/2021  AM191109A 10/31/2021  AM191186A 10/31/2021  AM191187A 10/31/2021  AM191188A 10/31/2021  AM191189A 10/31/2021  AM191190A 10/31/2021  AM191191A 10/31/2021  AM191192A 10/31/2021  AM191193A 10/31/2021  AM191194A 10/31/2021  AM191195A 10/31/2021  AM191244A 10/31/2021  AM191245A 10/31/2021  AM191246A 10/31/2021  AM191247A 10/31/2021  AM191294A 11/30/2021  AM191295A 11/30/2021  AM191296A 11/30/2021  AM191365A 11/30/2021  AM191366A 11/30/2021  AM191367A 11/30/2021  AM191392A 11/30/2021  AM191393A 11/30/2021  AM191394A 11/30/2021  AM191395A 12/31/2021  AM200001A 12/31/2021  AM200002A 12/31/2021  AM200003A 12/31/2021  AM200004A 12/31/2021  AM200005A 12/31/2021  AM200006A 12/31/2021  AM200045A 12/31/2021  AM200046A 12/31/2021  AM200047A 12/31/2021  AM200048A 12/31/2021  AM200049A 12/31/2021  AM200050A 12/31/2021  AM200051A 12/31/2021  AM200052A 12/31/2021  AM200053A 12/31/2021  AM200081A 12/31/2021  AM200082A 12/31/2021  AM200083 12/31/2021  AM200087A 12/31/2021  AM200088A 12/31/2021  AM200089 12/31/2021  AM200090 12/31/2021  AM200091 12/31/2021  AM200100 1/31/2022  AM200101 1/31/2022  AM200102 1/31/2022  AM200138 1/31/2022  AM200139 1/31/2022  AM200140 1/31/2022  AM200141 1/31/2022  AM200142 1/31/2022  AM200143 1/31/2022  AM200144 1/31/2022  AM200193 1/31/2022  AM200194 1/31/2022  AM200195 1/31/2022  AM200196 1/31/2022  AM200197 1/31/2022  AM200198 1/31/2022  AM200199 1/31/2022  AM200200 1/31/2022  AM200202 1/31/2022  AM200203 1/31/2022  AM200204 1/31/2022  AM200205 1/31/2022  AM200206 1/31/2022  AM200207 1/31/2022  AM200208 1/31/2022  AM200209 1/31/2022  AM200210 1/31/2022  AM200211 1/31/2022  AM200284 2/28/2022  AM200285 2/28/2022  AM200287 2/28/2022  AM200288 2/28/2022  AM200289 2/28/2022  AM200290 2/28/2022  AM200291 2/28/2022  AM200292 2/28/2022"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0733-2020", "product_description": "FENTANYL 800MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@1 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090842"], "brand_name": ["RALOXIFENE HYDROCHLORIDE"], "generic_name": ["RALOXIFENE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-266"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RALOXIFENE HYDROCHLORIDE"], "rxcui": ["1490065"], "spl_id": ["18588c41-973d-4ebc-e063-6294a90a5eed"], "spl_set_id": ["f5c25553-1546-451d-8069-c0f484c47741"], "package_ndc": ["60687-266-11", "60687-266-21"], "original_packager_product_ndc": ["69097-825"], "unii": ["4F86W47BR6"]}, "product_type": "Drugs", "event_id": "84898", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0854-2020", "product_description": "Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11", "product_quantity": "973 cartons", "reason_for_recall": "Failed Dissolution Specifications: Low out of specification results obtained during stability testing.", "recall_initiation_date": "20191204", "center_classification_date": "20200221", "termination_date": "20220804", "report_date": "20200219", "code_info": "Lot #:180276A, Exp date 02/29/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Saint Paul", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86246", "recalling_firm": "Ecolab Inc", "address_1": "1 Ecolab Pl", "address_2": "N/A", "postal_code": "55102-2739", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1539-2020", "product_description": "Hand Sanitizer (Alcohol 80% v/v) topical solution, 55 US GAL (208 L) EcoLab Inc 1 EcoLab Place St. Paul, MN 55102 USA, NDC 47593-624-21", "product_quantity": "305 drums", "reason_for_recall": "Discoloration and Presence of Foreign Substance", "recall_initiation_date": "20200730", "center_classification_date": "20200824", "termination_date": "20230519", "report_date": "20200902", "code_info": "Lot #: BP0D3091A0, BP0D3203A0, CR0D0553A0, CR0D0571A0, CR0D0577A0, CR0D0584A0, CR0E0482A0, CR0E0490A0, CR0E0499A0, CR0E0501A0, CR0E0520A0, FO0D0358A0, FO0D0440A0, FO0D0456A0, FO0D0464A0, FO0D0480A1, FO0D0490A0, FO0D0502A1, FO0D0517A1, FO0E0044A1, FO0E0061A1, FO0E0075A1, FO0E0094A0, FO0E0111A0, FO0E0119A1, FO0E0241A1, FO0E0256A1; Exp. Date April 2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0725-2020", "product_description": "CLON 800MCG/FENT 2000MCG/ML INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@15 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091664"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-338", "68180-339"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["1807888", "1807915"], "spl_id": ["14bf5106-3b8c-4375-8466-c158c8f8f614"], "spl_set_id": ["1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7"], "package_ndc": ["68180-338-01", "68180-338-02", "68180-338-03", "68180-339-09", "68180-339-01", "68180-339-02"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "85998", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States.", "recall_number": "D-1383-2020", "product_description": "Metformin Hydrochloride Extended-Release Tablets USP 1000 mg, 90 count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Manufactured by: Lupin Limited, Goa INDIA NDC 68180-339-09", "product_quantity": "95,886 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200707", "center_classification_date": "20200714", "termination_date": "20211223", "report_date": "20200722", "code_info": "Batch #   G807093 Jul-20  G807147 Jul-20  G807208 Jul-20  G807479 Jul-20  G807480 Jul-20  G807830 Jul-20  G807092 Jul-20  G809471 Jul-20  G808155 Aug-20  G808074 Aug-20  G808115 Aug-20  G900231 Nov-20  G900232 Nov-20  G903277 Mar-21  G903278 Mar-21  G903279 Mar-21  G903280 Mar-21  G903281 Mar-21  G903818 Apr-21  G904048 Apr-21  G904164 Apr-21  G906548 Jul-21  G907239 Aug-21  G907255 Aug-21  G907256 Aug-21  G907263 Aug-21  G001802 Jan-22  G001804 Jan-22  G001803 Jan-22  G001805 Jan-22  G001806 Jan-22  G001807 Jan-22  G001808 Jan-22  G808154 Aug-20  G900227 Nov-20  G900228 Nov-20  G900229 Nov-20  G900230 Nov-20  G906549 Jul-21  G906550 Jul-21  G906547 Jul-21  G907279 Aug-21  G907364 Aug-21  G001809 Jan-22  G001801 Jan-22  G002563 Feb-22  G002564 Feb-22"}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA205401"], "brand_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "generic_name": ["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["43975-277", "43975-278", "43975-279", "43975-280", "43975-282", "43975-281"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMPHETAMINE DL-ASPARTATE MONOHYDRATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "rxcui": ["861221", "861223", "861225", "861227", "861232", "861237"], "spl_id": ["d0db10e9-cc85-492d-9f29-663948539b07"], "spl_set_id": ["6438480f-1147-42b6-826d-4e1e1f8ff007"], "package_ndc": ["43975-277-10", "43975-278-10", "43975-279-10", "43975-280-10", "43975-282-10", "43975-281-10"], "is_original_packager": [true], "upc": ["0343975282102", "0343975281105", "0343975278105", "0343975280108", "0343975277108", "0343975279102"], "unii": ["O1ZPV620O4", "G83415V073", "JJ768O327N", "6DPV8NK46S"]}, "product_type": "Drugs", "event_id": "86584", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "455 Idc Rd Sw", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0044-2021", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10", "product_quantity": "13536 bottles", "reason_for_recall": "Labeling: Incorrect expiration date.  Product dated with 24-month expiration date instead of 18-months.", "recall_initiation_date": "20201009", "center_classification_date": "20201021", "termination_date": "20220119", "report_date": "20201028", "code_info": "Lot: 19S10 Exp. Sept. 2021, 19S11 Exp. Oct. 2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0665-2020", "product_description": "BAC 15MCG/HYDROM 15MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@23 Exp. 12/20/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1113-2020", "product_description": "Blood Clot Purger, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Berlin", "address_1": "15 Massirio Dr Ste 201", "reason_for_recall": "CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.", "address_2": "", "product_quantity": "11,250 bottles", "code_info": "Lot #: a) 81244, 81217, Exp. Date 01/2021 and b) 81245, Exp. Date 01/2021", "center_classification_date": "20200323", "distribution_pattern": "Product was distributed nationwide within the United States.", "state": "CT", "product_description": "Solifenacin Succinate Tablets, 5mg, packaged in a) 30-count bottles (NDC 51991-893-33) and b) 90-count bottles (NDC 51991-893-90) Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487; Manufactured by: Piramal Enterprises Limited Plot No 67-70, Sector -2 Pithampur 454 775, Dist, Dhar Madhya Pradesh, INDIA", "report_date": "20200325", "classification": "Class II", "openfda": {}, "recalling_firm": "Breckenridge Pharmaceutical, Inc", "recall_number": "D-1050-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "85186", "termination_date": "20201019", "more_code_info": "", "recall_initiation_date": "20200124", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Greenville", "state": "SC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86409", "recalling_firm": "PAI Holdings, LLC. dba Pharmaceutical Associates Inc", "address_1": "1700 Perimeter Rd", "address_2": "N/A", "postal_code": "29605-5252", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0015-2021", "product_description": "Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40", "product_quantity": "13480 cups", "reason_for_recall": "Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint", "recall_initiation_date": "20200909", "center_classification_date": "20201005", "termination_date": "20220222", "report_date": "20201014", "code_info": "Lots: C1EE Exp. 04/2021, BD82 Exp. 11/2020, BD83 Exp. 11/2020, C16D Exp. 02/2021, C563 Exp. 11/2021, C574 Exp. 11/2021"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1611-2020", "product_description": "WP Thyroid, Westhroid Pure, 1.5 Grain (97.5 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5850-2 ; b) 30 Tablets, NDC  64727-5850-4; c) 60 Tablets, NDC 64727-5850-5; d) 90 Tablets, NDC 64727-5850-6; e) 100 Tablets, NDC  64727-5850-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Guadalajara", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86199", "recalling_firm": "Incredible Products, SA de CV", "address_1": "Calle Castellanos Y Tapia 921", "address_2": "Col. Santa Maria", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "CA and GA", "recall_number": "D-1587-2020", "product_description": "Incredible Products Gelbac T Antibacterial Hand Gel (ethyl alcohol 80%), Kills 99.9% bacteria and germs, a) 4.2 Oz./125 mL bottle, NDC: 71761-000-00, UPC: 7502278002555, Distributed by Pacific Coast Global Inc. Chula Vista, CA 91911, Made in Mexico b) 33.8 Oz./1 L, UPC: 7502278002586, Made in Mexico By Incredible Products S.A. de C.V. alle Castellanos y Tapia 921, Oblatos, 44350 Guadalajara, Jal, MX.", "product_quantity": "N/A", "reason_for_recall": "Chemical Contamination: Product contains methanol as an active ingredient and is sub-potent for ethanol.", "recall_initiation_date": "20200806", "center_classification_date": "20200918", "termination_date": "20240626", "report_date": "20200930", "code_info": "Lot #: 001, Exp. 04/2023"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0708-2020", "product_description": "BUP 40MG/FENT 3000MCG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12102019@5 Exp. 12/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85212", "recalling_firm": "PharMEDium Services, LLC", "address_1": "36 Stults Rd", "address_2": "N/A", "postal_code": "08810", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1088-2020", "product_description": "ePHEDrine Sulfate, 5 mg per mL, 25 mg per 5 mL  in 0.9% Sodium Chloride, 5 mL syringe, For IV use, Preservative Free, PharMEDium 913 W Davis Ave Cleveland MS 38732 NDC 71030-003-09", "product_quantity": "375 units", "reason_for_recall": "Firm is recalling 46 lots of various products because of a lack of sterility assurance.", "recall_initiation_date": "20200316", "center_classification_date": "20200406", "termination_date": "20250214", "report_date": "20200415", "code_info": "193500012D, Exp 3/16/2020"}, {"status": "Terminated", "city": "Pickerel", "state": "", "country": "Canada", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "84265", "recalling_firm": "Med Man Distribution, Inc.", "address_1": "433 Pickerel River Rd", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1036-2020", "product_description": "UP2, Dietary Supplement, All Natural Libido for Men & Women, a) one pack, b) four pack, c) ten pack capsules per carton, Exclusively Manufactured and Formulated by: Buy Wise Marketing, 4234 I-75 Business Spur, Sault Ste Marie, MI 49783, Ultimatepleasure2.com.", "product_quantity": "1,680 cartons", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.", "recall_initiation_date": "20191108", "center_classification_date": "20200319", "termination_date": "20231017", "report_date": "20200325", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86022", "recalling_firm": "4e Brands North America, Llc", "address_1": "17806 Ih-10 Ste 300", "address_2": "N/A", "postal_code": "78257", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0025-2021", "product_description": "blumen Aloe ADVANCED HAND SANITIZER 70% ALCOHOL CONTENT (70% ethyl alcohol v/v), 3.4 fl. oz./100 mL bottle, Distributed in USA and Canada By: 4e Brands Northamerica LLC, 17806 IH-10W, Suite 300, San Antonio, Texas, 78257, Made in Mexico. UPC 8 14266 02358 7", "product_quantity": "17,359,247 total bottles and pumps", "reason_for_recall": "CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.", "recall_initiation_date": "20200711", "center_classification_date": "20201007", "termination_date": "20240226", "report_date": "20201007", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0686-2020", "product_description": "BUP 15MG/HYDROM 5MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@20 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1203-2020", "product_description": "Bi-Est (50/50)/Progesterone 1.25 mg/80 mL Cream 30 gm tube, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "2 tubes", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45006 Discard by: 7/18/2020; 45251 Discard by: 9/22/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1136-2020", "product_description": "Herpes V Balm, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0959-2020", "product_description": "Arginine Hydrochloride Injection, L-ARGININE  HCL  100MG/ML  INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0341-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10242019+53154, Exp 1/22/2020"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "85128", "recalling_firm": "Noven Therapeutics, LLC", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1043-2020", "product_description": "Daytrana (methylphenidate transdermal system) patches, Delivers 15 mg over 9 hours (1.6 mg/hr), 30-count box, Rx only, Manufactured for Noven Therapeutics, LLC. Miami, FL 33186, NDC 68968-5553-3", "product_quantity": "13761 boxes", "reason_for_recall": "Defective Delivery System: Out of specification for mechanical peel and shear.", "recall_initiation_date": "20200302", "center_classification_date": "20200319", "termination_date": "20230518", "report_date": "20200325", "code_info": "Lot#: 85942, Exp 03/2020; 86281, Exp 06/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0942-2020", "product_description": "BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [2ML] 6MG/ML INJ SUSP, For IM, IA, IT Use, Shake Well. Preservative Free. Discard Unused Portion, 2 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0620-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10022019+53004, Exp 2/28/2020; 11252019+53282, Exp 6/12/2020"}]